4.7 Article

Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Dual roles of B lymphocytes in mouse models of diet-induced nonalcoholic fatty liver disease

Martin Karl et al.

Summary: This study suggests that B lymphocytes play both detrimental and protective roles in the development of non-alcoholic fatty liver disease (NAFLD). The lack of secretion of pathogenic antibodies partially protects from NAFLD, while certain subsets of B cells provide additional protection. Regulatory B cells producing IL-10 may represent a protective subset of B cells.

HEPATOLOGY (2022)

Review Endocrinology & Metabolism

Hepatic Stellate Cell-Immune Interactions in NASH

James K. Carter et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease worldwide, and nonalcoholic steatohepatitis (NASH) is a more severe form characterized by significant hepatocellular injury, inflammation, and fibrosis. Recent research has shown that heightened immune cell activity and chronic inflammation play crucial roles in the development of NASH, with hepatic stellate cells (HSCs) being the key drivers of fibrosis.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Immunology

Immune cell-mediated features of non-alcoholic steatohepatitis

Thierry Huby et al.

Summary: NASH is a serious chronic liver disorder with increasing prevalence globally. Metabolic disturbance and the role of immune cells are crucial in its onset and progression. Understanding the mechanisms by which immune cells contribute to NASH pathogenesis is essential for the development of innovative drugs targeting NASH.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Gastroenterology & Hepatology

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Tracey G. Simon et al.

Summary: Population-based data in Sweden showed that all histological stages of NAFLD were linked with significantly increased overall mortality, and the risk escalated progressively with worsening histology. Excess mortality was mainly attributed to extrahepatic cancer and cirrhosis, while cardiovascular disease and HCC made modest contributions.
Article Cell Biology

Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH

Sabine Daemen et al.

Summary: The study reveals that changes in liver macrophage subsets during the pathogenesis of NASH are dynamically linked to pathologic tissue remodeling. High-fat, high-sucrose-diet feeding leads to a decrease in mature TIM4(pos) Kupffer cells (KCs) and an accumulation of monocyte-derived Tim4(neg) macrophages in the liver. Additionally, C-LAMs expressing Cx3cr1/Ccr2 fail to appear in the liver in Ccr2-deficient mice, preventing the formation of hCLS and resulting in increased liver fibrosis.

CELL REPORTS (2021)

Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cell Biology

TNF-Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization

Yuxin Luo et al.

Summary: TL1A expression is increased in NASH and promotes M1-type macrophage polarization and recruitment, exacerbating the pathological process of NASH.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Review Gastroenterology & Hepatology

The Emerging Role of B Cells in the Pathogenesis of NAFLD

Fanta Barrow et al.

Summary: NAFLD is a leading cause of abnormal liver function globally, with inflammatory B cells playing a crucial role in the progression of the disease, potentially promoting disease development through the production of proinflammatory cytokines.

HEPATOLOGY (2021)

Review Immunology

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases

Tamsin Cargill et al.

Summary: B cells play a crucial role in immune mediated liver diseases by potentially initiating and maintaining the diseases through producing autoantibodies and activating T cells. Future research should focus on developing targeted B cell therapies.

FRONTIERS IN IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Mechanisms of Fibrosis Development in NASH

Robert F. Schwabe et al.

GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis

Michitaka Matsuda et al.

SEMINARS IN LIVER DISEASE (2020)

Review Gastroenterology & Hepatology

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Zobair M. Younossi et al.

JOURNAL OF HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)

Stefania Bruzzi et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Article Multidisciplinary Sciences

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

Takashi Matsushita et al.

SCIENCE ADVANCES (2018)

Review Gastroenterology & Hepatology

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

Simona Leoni et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Multidisciplinary Sciences

Identification of an atypical monocyte and committed progenitor involved in fibrosis

Takashi Satoh et al.

NATURE (2017)

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Giulio Marchesini et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Giovanni Targher et al.

JOURNAL OF HEPATOLOGY (2016)

Article Endocrinology & Metabolism

Diminished immune response to vaccinations in obesity: Role of myeloid-derived suppressor and other myeloid cells

Shiyi Chen et al.

OBESITY RESEARCH & CLINICAL PRACTICE (2015)

Article Gastroenterology & Hepatology

B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease

Teruki Miyake et al.

HEPATOLOGY INTERNATIONAL (2013)

Article Nutrition & Dietetics

B cell activating factor in obesity is regulated by oxidative stress in adipocytes

Fujimasa Tada et al.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2013)

Article Medicine, Research & Experimental

Attenuated liver fibrosis in the absence of B cells

TI Novobrantseva et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)